KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Consolidated Net Income (2016 - 2025)

Pacific Biosciences Of California has reported Consolidated Net Income over the past 16 years, most recently at -$40.4 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at -$40.4 million for Q4 2025, down 1802.7% from a year ago — trailing twelve months through Dec 2025 was -$546.4 million (down 76.34% YoY), and the annual figure for FY2025 was -$546.4 million, down 76.34%.
  • Consolidated Net Income for Q4 2025 was -$40.4 million at Pacific Biosciences Of California, down from -$38.0 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for PACB hit a ceiling of $2.4 million in Q4 2024 and a floor of -$426.1 million in Q1 2025.
  • Median Consolidated Net Income over the past 5 years was -$69.8 million (2023), compared with a mean of -$85.4 million.
  • Biggest five-year swings in Consolidated Net Income: soared 102.89% in 2024 and later crashed 1802.7% in 2025.
  • Pacific Biosciences Of California's Consolidated Net Income stood at -$69.3 million in 2021, then dropped by 21.72% to -$84.4 million in 2022, then rose by 2.8% to -$82.0 million in 2023, then soared by 102.89% to $2.4 million in 2024, then crashed by 1802.7% to -$40.4 million in 2025.
  • The last three reported values for Consolidated Net Income were -$40.4 million (Q4 2025), -$38.0 million (Q3 2025), and -$41.9 million (Q2 2025) per Business Quant data.